Highlights include:

  • Real-life safety and efficacy of
    autologous SCT in elderly MM
  • Lenalidomide maintenance
    vs. observation for newly
    diagnosed MM
  • Subclonal TP53 copy number is
    associated with MM prognosis

Download here – Multiple Myeloma Research Review Issue 29